Literature DB >> 8373362

Interaction of CCAAT/enhancer-binding protein alpha and beta with the rat caeruloplasmin gene promoter.

C D Bingle1, R E Fleming, J D Gitlin.   

Abstract

To determine the mechanisms of expression of the rat caeruloplasmin gene, the promoter region was analysed by DNAase I footprinting. Using nuclear extract from rat liver, a prominent site of protein-DNA interaction was detected from -93 to -48 upstream of the caeruloplasmin gene transcription start and sequence analysis of this region revealed three potential CCAAT/enhancer-binding protein (C/EBP) consensus elements. Mobility-shift analysis using an oligonucleotide encoding this region identified specific binding of proteins from rat liver nuclear extract, and some of these complexes were supershifted using antisera to the C/EBP alpha and beta family members. Mobility-shift studies using a polypeptide encoding the DNA-binding domain of C/EBP alpha also revealed a specific interaction with this region of the caeruloplasmin promoter, and DNAase I footprinting using this polypeptide protected the identical region from -93 to -48. Co-transfection of expression plasmids encoding C/EBP alpha or a related leucine-zipper factor D-binding protein (DBP) revealed a C/EBP-specific increase in reporter gene activity in HepG2 cells transfected with caeruloplasmin-chloramphenicol acetyltransferase containing the -93 to -48 region. A similar result was obtained when these constructs were co-transfected into mouse L cells which were shown not to express the endogenous caeruloplasmin gene. Taken together, these data indicate a role for C/EBP alpha and beta in mediating transcription from the caeruloplasmin gene promoter and suggest that this region of the promoter is not responsible for tissue-specific expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8373362      PMCID: PMC1134478          DOI: 10.1042/bj2940473

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  Chemical evidence that proteolytic cleavage causes the heterogeneity present in human ceruloplasmin preparations.

Authors:  I B Kingston; B L Kingston; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

2.  Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin.

Authors:  M Sato; J D Gitlin
Journal:  J Biol Chem       Date:  1991-03-15       Impact factor: 5.157

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  The role of radiocopper in the diagnosis of Wilson's disease.

Authors:  I Sternlieb; I H Scheinberg
Journal:  Gastroenterology       Date:  1979-07       Impact factor: 22.682

5.  The role of the CCAAT/enhancer-binding protein in the transcriptional regulation of the gene for phosphoenolpyruvate carboxykinase (GTP).

Authors:  E A Park; W J Roesler; J Liu; D J Klemm; A L Gurney; J D Thatcher; J Shuman; A Friedman; R W Hanson
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

6.  Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.

Authors:  Z Cao; R M Umek; S L McKnight
Journal:  Genes Dev       Date:  1991-09       Impact factor: 11.361

7.  A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro.

Authors:  S C Williams; C A Cantwell; P F Johnson
Journal:  Genes Dev       Date:  1991-09       Impact factor: 11.361

8.  cAMP stimulates the C/EBP-related transcription factor rNFIL-6 to trans-locate to the nucleus and induce c-fos transcription.

Authors:  R Metz; E Ziff
Journal:  Genes Dev       Date:  1991-10       Impact factor: 11.361

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.